Frequencies for first 10,000 rows of lit_ref variable in demo2014q4 dataset : Literature Reference | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 9,523 95.23 95.23 , AUTORE F, INNOCENTI I, VANNATA B, C.. | 1 0.01 95.24 , BEAL K, GUTIN P, KARIMI S, CORREA D.. | 1 0.01 95.25 , CHIAPPELLA A, GHIONE P, CECCARELL.. | 1 0.01 95.26 , CHIAPPELLA A, FRANCESCHETTI S, CAST.. | 1 0.01 95.27 , CHOI T AND KIRKWOOD J. REPLY TO THE.. | 1 0.01 95.28 , CILLI A, GORCZYNSKI R, BISGIN A, AN.. | 1 0.01 95.29 , COLD S, TANGE U, BALSLEV E, AND NIE.. | 1 0.01 95.30 , CUNNINGHAM D, HAWKES E, JACK A, QI.. | 1 0.01 95.31 , DENIS S, MAGALI R, JACQUES B, ROSIN.. | 1 0.01 95.32 , EFFICACE F, MANDELLI F, AVVISATI G,.. | 1 0.01 95.33 , GARCIA LUQUE A, MATEOS GALVAN JM, V.. | 1 0.01 95.34 , GARCIA S, GAVRIATOPOULOU M, MOREL P.. | 1 0.01 95.35 , HART L, BENDELL J, INFANTE J, JO.. | 1 0.01 95.36 , IWASAWA S, MINATO K, MIURA Y, GEMMA.. | 1 0.01 95.37 , JARDIN F, LEDUC I, DENNETIERE S, CH.. | 1 0.01 95.38 , KOZINSKA-PRZYBYL O, MIKASZEWSKA-SOK.. | 1 0.01 95.39 , LAOUENAN C, MARCELLIN P, LAPALUS M,.. | 1 0.01 95.40 , LAURENTI L, INNOCENTI I, AUTORE F, .. | 1 0.01 95.41 , LISSANDRINI L, ZAMBELLO, R, PAOLINI.. | 1 0.01 95.42 , LUMINARI S, ROSSI G, MAMMI C, MARCH.. | 1 0.01 95.43 , MCGRATH M, MURPHY A, MURPHY P, LALI.. | 1 0.01 95.44 , MCGRATH M, MURPHY A, MURPHY P, LALI.. | 1 0.01 95.45 , MERLI F, LUMINARI S, ILARIUCCI F, .. | 1 0.01 95.46 , MERLI F, LUMINARI S, ROSSI G, MAMMI.. | 1 0.01 95.47 , MICHAELSSON K. ASPENBERG P. MICHAEL.. | 1 0.01 95.48 , RAINA V. AN UPDATE ANALYSIS OF RITU.. | 1 0.01 95.49 , ROSSI G, DELAINI F, ROMANI C, POGLI.. | 1 0.01 95.50 , SHAH K, BUSAIDY N, WAGUESPACK S, HA.. | 1 0.01 95.51 , SOBH M, MOHTY M, SOCIE G, TABRIZI R.. | 1 0.01 95.52 , SOLOVIYOV S, BEKETOVA T, VASILIEV V.. | 1 0.01 95.53 , SOLOVIYOV S, BEKETOVA T, VASILIEV V.. | 1 0.01 95.54 , SPECKS U, MERKEL P, SEO P, SPIERA R.. | 1 0.01 95.55 , STEFONI V, PELLEGRINI C, BROCCOLI A.. | 1 0.01 95.56 , THEODOULOU M, FEIGIN K, PATIL S, GE.. | 1 0.01 95.57 , TIRELLI U, FRATINO L, BALZAROTTI M,.. | 1 0.01 95.58 , VAN DER JAGT R, KAHL B, WOOD P, HAW.. | 1 0.01 95.59 , WEI W, KORBLING M, TURTURRO F, AHM.. | 1 0.01 95.60 , WEI W, KORBLING M, TURTURRO F, AHME.. | 1 0.01 95.61 , XU Q, CHEN X, PAN Y AND WANG M. EFF.. | 1 0.01 95.62 , YAMADA SHIN, SANO TOMOYASU, ET AL. .. | 1 0.01 95.63 , YANAGITANI N, KUDO K, KAWANO Y, SA.. | 1 0.01 95.64 , YASUNO M, ISHIGURO M, KAMEOKA S, SH.. | 1 0.01 95.65 , ZIJLSTRA J. DOORDULJN J. BOHMER L. .. | 1 0.01 95.66 . CHEMORADIATION OF HEPATIC MALIGNANC.. | 1 0.01 95.67 ?????,????,?????,?????,?????,?????,??.. | 1 0.01 95.68 A NEUPREZ, E ROMPEN, JM CRIELAARD ET .. | 1 0.01 95.69 A RETROSPECTIVE STUDY OF 13 PATIENTS .. | 2 0.02 95.71 ABDALLA A, RAMLY S, BOERS P, CASSERLY.. | 1 0.01 95.72 ACQUISTAPACE G, ROSSI M, GARBI M, COS.. | 1 0.01 95.73 AFT R, NAUGHTON M, TRINKAUS K, WATSON.. | 1 0.01 95.74 AKATSUKA M. TWO CASES OF INCREASED PT.. | 1 0.01 95.75 AKIRA Y, EMI T.Y, KATSUHIRO S AND MAS.. | 1 0.01 95.76 AKIYAMA H, AKIYAMA HIROTO, FUJITA KEN.. | 1 0.01 95.77 AKIYAMA H. CORRELATION BETWEEN ANTI-T.. | 1 0.01 95.78 ALTINTAS ND, IZDES S, YUCEL S, SUHER .. | 1 0.01 95.79 ARUN P, SAHNI S. METHYLPHENIDATE AND .. | 1 0.01 95.80 AZUMA K, TANAKA MIDORI, ISHII HIDENOB.. | 1 0.01 95.81 BAHRO M, KAMPF C, STRNAD J. CATATONIA.. | 1 0.01 95.82 BALDO, B.; SIDE EFFECTS OF CYTOKINES .. | 1 0.01 95.83 BANSAL N, ARORA A, KUMARAN V, MEHTA N.. | 1 0.01 95.84 BARDET R. BONE PAIN IN PATIENT TREATE.. | 1 0.01 95.85 BEER B, LIBISELLER K, OBERACHER H, PA.. | 1 0.01 95.86 BELANI R, AMUNDSON S AND BELANI R. AN.. | 1 0.01 95.87 BELLMUNT J, SUAREZ C, GALLARDO E, ROD.. | 1 0.01 95.88 BENE J, AUFFRET M, POTEY C, GAUTIER S.. | 1 0.01 95.89 BEPPU T, EMI Y, TOKUNAGA S, OKI E, SH.. | 1 0.01 95.90 BHOME R, PENN H. RHABDOMYOLYSIS PRECI.. | 1 0.01 95.91 BONNER WJ, ANGELO M. GABAPENTIN WITHD.. | 1 0.01 95.92 BOUMANS D, DE VRIES PAM, RIKKEN NET, .. | 1 0.01 95.93 BRACKETT J. USE OF ALLOPURINOL IN CHI.. | 1 0.01 95.94 BRIAND V, ESCOLANO S, JOURNOT V, MASS.. | 1 0.01 95.95 BRONSTEIN AC, SPYKER DA, CANTILENA LR.. | 30 0.30 96.25 BRUNO MV, DONADONI G, RE A, SPINA M, .. | 1 0.01 96.26 BRUNO SOARES J, VIEGAS L, LOPES A, SI.. | 1 0.01 96.27 BUDAS SJ, SEENAN JP, JAMIESON N, CAHI.. | 1 0.01 96.28 CALLEJA J.L.. EFFICACY AND SAFETY OF .. | 1 0.01 96.29 CARBAJAL R, YISFALEM A, PRADHAN N, BA.. | 1 0.01 96.30 CATALANO A, BASILE G, LASCO A. HYPOCA.. | 1 0.01 96.31 CAVIGELLI-BRUNNER A, SCHWEIGER M, KNI.. | 1 0.01 96.32 CELEBI ZK, AKTURK S, OKTAY EI, DUMAN .. | 1 0.01 96.33 CHAKRABORTY K, DAN A. LITHIUM TOXICIT.. | 1 0.01 96.34 CHARACTERISTICS OF PML CASES IN MULTI.. | 2 0.02 96.36 CHATTERJEE SB, BAGHIANA KS. A CASE OF.. | 1 0.01 96.37 CHEN SN, LIN CJ, LI K-H, HWANG JF. CH.. | 1 0.01 96.38 CHIKARA UEYAMA ET AL. | 1 0.01 96.39 CHLEBICKA I, JANKOWSKA-KONSUR A, MAJ .. | 1 0.01 96.40 CSIFO-NAGY B, HULIK E, ZSOLDOS GM, GE.. | 1 0.01 96.41 CUEVAS J, SALA MP, BALADON L, MINAMBR.. | 1 0.01 96.42 CURRY SC, PADILLA-JONES A, O^ CONNOR .. | 1 0.01 96.43 CURRY SC, PADILLA-JONES A, O^ CONNOR .. | 1 0.01 96.44 CURRY SC, PADILLA-JONES A, O^ CONNOR .. | 1 0.01 96.45 CURRY SC, PADILLA-JONES A, O^CONNOR A.. | 3 0.03 96.48 CURRY SC, PADILLA-JONES A, O^CONNOR A.. | 1 0.01 96.49 DEMIRCI, A.. SUNITINIB-INDUCED SEVERE.. | 1 0.01 96.50 DESAI N, CHERKAS D, KIM H, SMITH S, M.. | 1 0.01 96.51 DIAS JG, CHAMBEL M, SOUSA F, PRATES S.. | 1 0.01 96.52 DIETERICH M, MANN E, WAGNER K, KRAMER.. | 1 0.01 96.53 DIXON AJ, WINEARLS CG, DUNNILL MS. IN.. | 1 0.01 96.54 DOSTAL M ET AL. PREGNANCY OUTCOME FOL.. | 2 0.02 96.56 DR. SEIJI SHIDA. HODGKIN^S LYMPHOMA F.. | 1 0.01 96.57 DROSTE J, ET AL. SURGICAL EXCISION OF.. | 1 0.01 96.58 E.M KALOGIROU; S MERKOURAS; I MELAKOP.. | 1 0.01 96.59 EGUCHI K, HOSIDE S, KARIO K. A CASE O.. | 1 0.01 96.60 EITEL I, WOHRLE J, SUENKEL H, MEISS.. | 1 0.01 96.61 ELENI K, STAMATOULA G, RODANTHI T, CH.. | 1 0.01 96.62 EMRE S, AKOGLU G, METIN H, DEMIRSEREN.. | 1 0.01 96.63 EOSINIPHILIC FASCIITIS-LIKE DISORDER .. | 1 0.01 96.64 ERHARDT A, KOLLIGS FT, DOLLINGER M, S.. | 1 0.01 96.65 FALCHI, L.. FEASIBILITY OF HIGH-DOSE .. | 1 0.01 96.66 FAMULARO G, GASBARRONE L, GALLUZZO M,.. | 1 0.01 96.67 FERRE L, MOIOLA L, SANGALLI F, RADAEL.. | 1 0.01 96.68 FINGOLIMOD TREATMENT AFTER NATALIZUMA.. | 1 0.01 96.69 FLAMARIQUE I, CASTRO-FORNIELES J, GAR.. | 1 0.01 96.70 FLORES J, RITO Y, RIVAS V, CELIS L, S.. | 1 0.01 96.71 FOURNIER JB, CUMMINGS F, CANNELLA J, .. | 1 0.01 96.72 FRAISON J-B, GUILPAIN P, SCHIFFMANN A.. | 1 0.01 96.73 FUJIKAWA C, FUJIKAWASHOU [FUJIKAWASHO.. | 1 0.01 96.74 FUJISAWA T, MORIYA C, MIZUTANI Y, SUZ.. | 1 0.01 96.75 FUJISAWA T, MORIYA C, MIZUTANI Y, SUZ.. | 1 0.01 96.76 FUKUDA Y, MOMOI N, MITSUTOMO M, AOYAN.. | 1 0.01 96.77 FUKUZAWA N, IWAHARA N, SUZUKI H, KAWA.. | 1 0.01 96.78 GANSKE CM, HORNING KK. LEVOFLOXACIN-I.. | 1 0.01 96.79 GARBE E, ANDERSOHN F, BRONDER E, SALA.. | 1 0.01 96.80 GARCIA SS, ATKINS JT, FALCHOOK GS, TS.. | 1 0.01 96.81 GARCIA SS, ATKINS JT, FALCHOOK GS, TS.. | 1 0.01 96.82 GARY BIRNBAUM AND JANE IVERSON. DALFA.. | 1 0.01 96.83 GENTILE S.PREGNANCY EXPOSURE TO SECON.. | 1 0.01 96.84 GERALDO DIAS J, CHAMBEL M, SOUSA F, P.. | 1 0.01 96.85 GERRIE AS, MIKHAEL JR, CHENG L, JIANG.. | 1 0.01 96.86 GERVASONI C, MILAZZOA L, PEZZANIA D, .. | 1 0.01 96.87 GLADKOV O, ELSAESSER R, BUCHNER A, BI.. | 1 0.01 96.88 GLATIRAMERE: CANCERS DE SEIN?. LA REV.. | 1 0.01 96.89 GOMEZ M MA, MARTOS S MD, MARCOS G SA,.. | 1 0.01 96.90 GONZA LEZ-CRUZ V, FERRER GARCIA JC, M.. | 1 0.01 96.91 GONZALEZ-CRUZ VI, FERRER-GARCIA JC, N.. | 1 0.01 96.92 GROSSET-JANIN C. A RETROSPECTIVE STUD.. | 1 0.01 96.93 GROSSET-JANIN C. A RETROSPECTIVE STUD.. | 2 0.02 96.95 GUIDDIR T, FREMOND M, TRIKI T, CANDON.. | 1 0.01 96.96 GUIDDIR T, FREMOND M, TRIKI TB, CANDO.. | 1 0.01 96.97 GUIDDIR T, FREMOND M, TRIKI TB, CANDO.. | 1 0.01 96.98 GUIDDIR T, FREMOND M, TRIKI TB, CANDO.. | 1 0.01 96.99 HAGEMEISTER F, RODRIGUEZ MA, DEITCHER.. | 1 0.01 97.00 HARTUNG B, MERK HF, HUCKENBECK W, DAL.. | 1 0.01 97.01 HASHIMOTO N, YAMAGA KOSUKE, HANAFUSA .. | 1 0.01 97.02 HASTIER P, LONGO F, BUCKLEY M, CHICHM.. | 1 0.01 97.03 HAYAKAWA S, ET AL.. P3-11-2 A CASE OF.. | 1 0.01 97.04 HAYASHI N, HAYASHI N, NAKAYAMA G, ISH.. | 1 0.01 97.05 HESLOP OD, ROYE-GREEN K, COARD K, MUL.. | 1 0.01 97.06 HIGASHIDA M, HIGASHIDA MASAHARU P12-8.. | 1 0.01 97.07 HIRONAKA S, TSUBOSA Y, MIZUSAWA J, KI.. | 1 0.01 97.08 HIRONAKA S, TSUBOSA Y, MIZUSAWA J, TO.. | 1 0.01 97.09 HITOM T, TAKAHASHI H ET .,. THREE CAS.. | 1 0.01 97.10 HOEGHOLM A, RASMUSSEN SW, KRISTENSEN .. | 1 0.01 97.11 HOFKENS PJ, DE WINTER S, VANBRABANT P.. | 1 0.01 97.12 HOKAO K, UMEDA N, MURATA K, HAYASHI H.. | 1 0.01 97.13 HOKAO K, UMEDA N, MURATA K, HAYASHI H.. | 1 0.01 97.14 HOKAO K, UMEDA N, MURATA K, HAYASHI H.. | 1 0.01 97.15 HYNYNEN J, KOMULAINEN T, TUKIAINEN E,.. | 1 0.01 97.16 ICHIRO KAWAHARA. PNEUMOCYSTIS CARINII.. | 1 0.01 97.17 IIMURA Y, HIROSE KAZUYUKI, ONO MASATO.. | 1 0.01 97.18 IKKO K, MAKINO K, ICHIHARA A, FUKUSHI.. | 1 0.01 97.19 IKODA A,ITOSHIMA S,KATO T,YUNO A,TATS.. | 1 0.01 97.20 IKUMA M. A CASE OF EXACERBATION OF TU.. | 1 0.01 97.21 INOUE T, KAWASHIMA R, SUZUKI T, OHASH.. | 3 0.03 97.24 INWARDS D, FISHKIN P, LAPLANT BR, DRA.. | 1 0.01 97.25 ITOH H ET AL.. A CASE OF HYPOPHOSPHAT.. | 1 0.01 97.26 ITURRINO, D.M.. SEVERE HYPONATREMIA I.. | 1 0.01 97.27 IWASAKI M, HIRAI H, KONO T, KANENARI .. | 1 0.01 97.28 J BYRD. IMPROVED EFFICACY USING RITUX.. | 1 0.01 97.29 JAIN H, SHET T, SRIDHAR E, MENON H, D.. | 1 0.01 97.30 JAIN H, SHET, T. SRIDHAR, E. MENON, H.. | 1 0.01 97.31 JENEROWICZ D, SZULCZYNSKA-GABOR J, PO.. | 1 0.01 97.32 K. SADA. A CASE OF BILATERAL FEMORAL .. | 1 0.01 97.33 KALACHAND R, MONGAN A, DOHERTY M, KIN.. | 1 0.01 97.34 KALITA J, BHOI SK, MISRA KU. FATAL ST.. | 1 0.01 97.35 KANAZAWA O. RECONSIDERATION OF ABNORM.. | 1 0.01 97.36 KANDA T, FUKUDA S, FUKUI N, KAGEYAMA .. | 1 0.01 97.37 KANDA T. A CASE WITH GASTROINTESTINAL.. | 1 0.01 97.38 KANEKO S, OTA M, MORITA E. A CASE OF .. | 1 0.01 97.39 KATHURIA S, RAMESH V, SINGH A. PENTAZ.. | 1 0.01 97.40 KATO B, IWASE H, SHIMADA M, TSUZUKI T.. | 2 0.02 97.42 KATO D. A CASE OF RHEUMATOID ARTHRITI.. | 1 0.01 97.43 KATO M, OISO N, NOZAKI Y, ET AL. LETT.. | 1 0.01 97.44 KATSUYUKI KATAYAMA ET AL.. OUR EXPERI.. | 1 0.01 97.45 KAWANO ET AL. A CASE OF SEVERE HYPOGL.. | 1 0.01 97.46 KAWASE T,KIMURA Y,KAIDO M,KAWABATA R,.. | 1 0.01 97.47 KENSUKE UESUGI, ET.AL.. A CASE REPORT.. | 1 0.01 97.48 KICKA M, OLSZOWY Z, JANKOWSKI Z, CELI.. | 1 0.01 97.49 KILLESTEIN J, VENNEGOOR A, VAN GOLDE .. | 1 0.01 97.50 KIMURA KE, TAKEDA R, TACHIBANA N, KUR.. | 1 0.01 97.51 KIMURA Y,MISAO N,HASHIMOTO K,TAKAHASH.. | 1 0.01 97.52 KIRATLI H, DIKMETAS O. BILATERAL LACR.. | 1 0.01 97.53 KITAGAWA A, TAKANASHI M, HONDA T, AND.. | 1 0.01 97.54 KNOX E, PAWLUCZYK S. PISA SYNDROME DU.. | 1 0.01 97.55 KOBAYASHI S, KIKUTA A, ITO M, SANO H,.. | 1 0.01 97.56 KOBAYASHI Y., ISHIKAWA N., FUJII Y., .. | 1 0.01 97.57 KODA Y, MORI T, SHIMIZU T, KATO J, YA.. | 1 0.01 97.58 KOGA T, ET AL.. A CASE OF FANCONI SYN.. | 1 0.01 97.59 KOGOI A.SELECTIVE SEROTONIN REUPTAKE .. | 1 0.01 97.60 KONDO M, MURAKAWA Y, MATSUMURA T, MAT.. | 1 0.01 97.61 KONIG, K.. THE EFFECT OF SILDENAFIL O.. | 1 0.01 97.62 KOREEDA N, FUJITA H, AOZASA N, SUGAYA.. | 1 0.01 97.63 KOUDELKOV? M, SZABOV? Z, HAVRDOV? E, .. | 1 0.01 97.64 KUKLA P, BARANCHUK A, JASTRZEBSKI M, .. | 1 0.01 97.65 KUNAC D, TATLEY MV, GRIMWOOD K, REITH.. | 1 0.01 97.66 KUNIO H; KATO R; IKEMOTO J; IKEGAME K.. | 1 0.01 97.67 LAI EC, HSIEH C, YANG YK, LIN S. DETE.. | 1 0.01 97.68 LAI MW. 2005 ANNUAL REPORT OF THE AME.. | 1 0.01 97.69 LARSEN TR, GELAYE A, DURANDO C. ACUTE.. | 1 0.01 97.70 LAWATTANATRAKUL N. ACETAMINOPHEN PSI .. | 1 0.01 97.71 LEDINEK A H, ROT U, SEGA S. COULD LON.. | 1 0.01 97.72 LEEAPHORN N, STOKES MB, UNGPRASERT P,.. | 1 0.01 97.73 LEFEBER G, JANSEN P, VAN PUIJENBROEK .. | 1 0.01 97.74 LESIAK A, OLEJNICZAK I, TYLMAN MR, JE.. | 1 0.01 97.75 LEVINSON M, GIBSON A, STEPHENSON G. S.. | 1 0.01 97.76 LEWIS J, ALSOP J. A 13-YEAR REVIEW OF.. | 8 0.08 97.84 LI CAVOLI G. COMMENTARY ON ^A CASE OF.. | 1 0.01 97.85 LIN R, LI Y, XU X, FAN Z, JIANG Q, HU.. | 1 0.01 97.86 LOCHHEAD J.. DOXYCYCLINE INDUCED INTR.. | 1 0.01 97.87 MAKRIS M. PROTHROMBIN COMPLEX CONCENT.. | 1 0.01 97.88 MARI OKADA. A CASE OF HYPOKALEMIA ACC.. | 1 0.01 97.89 MARIN HUARTE N. OXCARBAZEPINE POISONI.. | 1 0.01 97.90 MARINOVIC MA, ROJAS R. CASE REPORT: H.. | 1 0.01 97.91 MARRAFFA JM, HOLLAND MG, SULLIVAN RW,.. | 2 0.02 97.93 MARTINEZ-YELAMOS S, RAMIO-TORRENTA L,.. | 1 0.01 97.94 MARZANO A. HEPATOCELLULAR CARCINOMA. .. | 1 0.01 97.95 MASATOSHI MURAKAMI. A CASE OF A PATIE.. | 1 0.01 97.96 MASUI A. CONSIDERATION OF 2 CASES PRE.. | 1 0.01 97.97 MATSUMOTO Y, MAEMONDO M, ISHII Y, OKU.. | 2 0.02 97.99 MATSUMOTO Y, MAEMONDO M, ISHII Y, OKU.. | 1 0.01 98.00 MATSUOKA Y, HASHIZUME M. MOYAMOYA DIS.. | 1 0.01 98.01 MAUNG K, O^SHAUGHNESSY J, AND SLEDGE .. | 1 0.01 98.02 MELANOMA COMPLICATING TREATMENT WITH .. | 1 0.01 98.03 MENDOZA RC, ALAMDEW Y, BAUMSTEIN D, T.. | 1 0.01 98.04 MICHELS J, SPANO JP, BROCHERIOU I. DE.. | 1 0.01 98.05 MILIC R, PLAVEC G, TUFEGDZIC I, TOMIC.. | 1 0.01 98.06 MILTIADOUS G, ELISAF M. ACID-BASE BAL.. | 1 0.01 98.07 MIO CL, LI J, MOWREY AD, KHARA HS, JO.. | 1 0.01 98.08 MITSIKOSTAS DD, ET AL. NATALIZUMAB-R.. | 1 0.01 98.09 MITSUHA H, YOSHINORI U, OSAMU F, TOSH.. | 1 0.01 98.10 MITTAINE M, MAS E, RITTIE J-L, DULAC .. | 1 0.01 98.11 MITTAINE M, MAS E, RITTIE JL, DULAC Y.. | 1 0.01 98.12 MIYAMA H, YASAKA M, TSURUSAKI Y, MAED.. | 1 0.01 98.13 MOTOHASHI R, IKEUCHI H, HIROMURA K, O.. | 1 0.01 98.14 MOUSA OYS, KHALAF R, SHANNON RL, EGW.. | 1 0.01 98.15 MOUSA OYS, KHALAF R, SHANNON RL, EGWI.. | 1 0.01 98.16 MOWRY, J.. 2012 ANNUAL REPORT OF THE .. | 1 0.01 98.17 MUEHLSCHLEGEL S, CARANDANG R, HALL W,.. | 2 0.02 98.19 MUEHLSCHLEGEL S, CARANDANG R, HALL W,.. | 1 0.01 98.20 MUEHLSCHLEGEL S., CARANDANG R., HALL .. | 1 0.01 98.21 MUEHLSCHLEGEL S., CARANDANG R., HALL .. | 1 0.01 98.22 MUKAI, R, ET AL.. Y1-2 TWO CASES OF O.. | 1 0.01 98.23 N. DOUGLAS. A PILOT PHASE II TRIAL OF.. | 1 0.01 98.24 NAGATA N, NIIKURA R, AOKI T, SHIMBO T.. | 1 0.01 98.25 NAKA M. RHINSO DERMA. 2014;56 (12):19.. | 1 0.01 98.26 NAKAMOTO M, MASAKADO M, ETO T, UEDA A.. | 1 0.01 98.27 NAKAMURA M, YAMADA Y, TAKAHARI D, MAT.. | 1 0.01 98.28 NAKAO M, ARAKI M, NAKAMURA K, ET AL. .. | 1 0.01 98.29 NAKATANI T, MURATA Y, SEGUCHI O, YANA.. | 1 0.01 98.30 NAKATANI T, MURATA Y, SEGUCHI O, YANA.. | 1 0.01 98.31 NAKUI M,SENDA G,SUZUKI R. TWO CASES O.. | 1 0.01 98.32 NAVARRO R, LLAMAS M, GALLO E, SANCHEZ.. | 1 0.01 98.33 NEHRA V, ZEIN CO. 40-YEAR-OLD MAN WIT.. | 1 0.01 98.34 NIELSEN D, BRIEM-RICHTER A, SORNSAKRI.. | 1 0.01 98.35 NISHIKAWA J, TANAKA T, SUGIYAMA T. ME.. | 1 0.01 98.36 NOVIKOV PI, SMITIENKO IO, MOISEEV SV... | 1 0.01 98.37 NOWAK M, STRZELCZYK A, REIF PS, SCHOR.. | 1 0.01 98.38 NOZZA S, GALLI L, VISCO F, SORIA A, C.. | 1 0.01 98.39 NOZZA S, GALLI L, VISCO F, SORIA A, C.. | 1 0.01 98.40 NOZZA S, GALLI L, VISCO F, SORIA A, C.. | 1 0.01 98.41 NUMATA T, HONMA YUUKI, NUMATA TAKESHI.. | 1 0.01 98.42 OFFIDANI M,CORVATTA L,CARAFFA P,LIBER.. | 1 0.01 98.43 OHASHI Y, TAKAISHI H, EJIRI J, HIRAYA.. | 1 0.01 98.44 OHISHI Y, SHIN Y, MIEDA H, KAWANOUE N.. | 1 0.01 98.45 OKADA TOSHIAKI. OUR EXPERIENCE OF CRI.. | 1 0.01 98.46 OKAMOTO K, YONEI N, YAMAMOTO Y, FURUK.. | 1 0.01 98.47 OKAMOTO T, AKIYOSHI K, MIYAHARA H, SU.. | 1 0.01 98.48 OLIVEIRA AM, LOURENCO L, RODRIGUES CG.. | 1 0.01 98.49 ONAKA T, YONEZAWA A, IMADA K. 2 CASES.. | 1 0.01 98.50 ONUIGBO MA, AGBASI N. QUADRUPLE WHAMM.. | 1 0.01 98.51 OPRIS D, MAZILU D, SAULESCU I, LONESC.. | 1 0.01 98.52 ORLANDI EM, ROCCA B, PAZZANO AS, GHIO.. | 1 0.01 98.53 OTANI K,NUKUI Y,YOSHIKAWA M,SYOJI K,S.. | 1 0.01 98.54 OYAMA T, TANAKA S, HIRATSUKA Y, WATAN.. | 1 0.01 98.55 OZAWA A,HASEGAWA M,NAGAYAMA N,MATSUSH.. | 1 0.01 98.56 PAMIES A, CASTRO S, POVEDA MJ, FON.. | 1 0.01 98.57 PEDERSEN JS. A FATAL OVERDOSE OF VENL.. | 1 0.01 98.58 PLUMB JOM, STEWART C, EDDLESTON M, DE.. | 1 0.01 98.59 PRIGNANO F, BONCIOLINI V, BONCIANI D,.. | 1 0.01 98.60 PROKES M. EFFECTIVENESS OF PALIPERIDO.. | 1 0.01 98.61 RAFANIELLO C, IANNIELLO B, DE VIZIA M.. | 1 0.01 98.62 RAGHAVENDRAN R, SHIPMAN AR, LANGMAN G.. | 1 0.01 98.63 RAMESHWAR NATH C, PATIDAR SURYA P, DE.. | 1 0.01 98.64 RANKIN BT, JARIWALA S. GRADED CHALLEN.. | 1 0.01 98.65 RASKINA T, AVERKIEVA Y, MALYSHENKO O.. | 1 0.01 98.66 RENE VOLLENBROICH, DANIEL WEILENMANN... | 1 0.01 98.67 REPORTER KNOWN TO LICENSEE, FUKUDA KE.. | 1 0.01 98.68 REPORTER KNOWN TO LICENSEE, MATSUI T,.. | 1 0.01 98.69 RINALDUZZI S, CIPRIANI AM, ACCORNERO .. | 1 0.01 98.70 RIZOS E, TSIGKAROPOULOU E, KANAKAKI M.. | 1 0.01 98.71 RK CROWLEY, M KILBANE, TFJ KING, ET. .. | 1 0.01 98.72 RODRIGUEZ A,GARCIA J,CONESA Z. CASE R.. | 1 0.01 98.73 RUIZ-TOVAR J, GAMALLO C.. DUODENITIS .. | 1 0.01 98.74 RYU Y, YAMAGUCHI KEIZO, OGATA YUTAKA,.. | 1 0.01 98.75 S FILIP. APLASTIC ANEMIA AS A CAUSE O.. | 1 0.01 98.76 SACCO A, MORICI N, BELLI O, BOSSI I, .. | 1 0.01 98.77 SAFRANO L, BOURNEAU-MARTIN D, LE CLEC.. | 1 0.01 98.78 SAITO M.. P3-03-3: A CASE OF ANAPHYLA.. | 1 0.01 98.79 SALIBA L, PETITPAIN N, BAGHERI H, BAL.. | 1 0.01 98.80 SANDHOLDT, L.H.. PROTON PUMP INHIBITO.. | 1 0.01 98.81 SANO T, RYUHEI U, HISASHI U. PRACTICA.. | 1 0.01 98.82 SANTOS-CUBINA J, TORRES-RODRIGUEZ A, .. | 1 0.01 98.83 SARMA A,ROSSI J,CONNORS J,GIUGLIANO R.. | 1 0.01 98.84 SASAKI T. A CASE OF RHEUMATOID ARTHRI.. | 1 0.01 98.85 SATO A, SAKAI N, SHINBO J, HASHIDATE .. | 1 0.01 98.86 SATOH T, SATO, T. KAKURAI, K. NAKAIZU.. | 1 0.01 98.87 SAVARD M,DUPRE N,TURGEON A. POLG MITO.. | 1 0.01 98.88 SAYAKA KASHIWAGI ET AL.,. THE 49TH KI.. | 1 0.01 98.89 SCHWARZ E, HALCOMB S, SAMPSON C, STEN.. | 1 0.01 98.90 SELVI PS, TITOS JA, RIZO AC, RUIZ ME.. | 1 0.01 98.91 SELVI SABATER P, ESPUNY MIRO A, MUNOZ.. | 1 0.01 98.92 SENOO A. 29TH ANNUAL MEETING OF THE J.. | 1 0.01 98.93 SEPULVEDA, M., LLUFRIU, S., BLANCO, Y.. | 1 0.01 98.94 SERRA D, RAMOS L, BRINCA A, GONCALO M.. | 1 0.01 98.95 SERTOZ N, BAS E, SARGIN A, KARAMAN S... | 1 0.01 98.96 SHAH AD, WOOD D, DARGAN P. UNDERSTAND.. | 1 0.01 98.97 SHAHI V, FUGATE J, KALLMES D AND RABI.. | 1 0.01 98.98 SHIBUYA J, ISHIKI YOSHITO AND HANDA M.. | 1 0.01 98.99 SHIGEKI ITO ET AL.. ^STUDY OF THREE C.. | 1 0.01 99.00 SHIMADA, T.. SECONDARY LEUKEMIA AFTER.. | 1 0.01 99.01 SHIOZAWA K, WATANABE M, IKEHARA T, MA.. | 1 0.01 99.02 SHIRATSUCHI T.. PHARMACOTHERAPY THAT .. | 1 0.01 99.03 SHUSTER, J. ISMP ADVERSE DRUG REACTIO.. | 1 0.01 99.04 SHUSTER, J.. ACUTE INTERSTITIAL NEPHR.. | 1 0.01 99.05 SHUSTER, J.. ISMP ADVERSE DRUG REACTI.. | 1 0.01 99.06 SINGH N,QADIR M. DO NO HARM: CALCIUM .. | 1 0.01 99.07 SIVARAMAN A, BORUM M. METASTATIC MELA.. | 1 0.01 99.08 SONG S M. LIVER TRANSPLANTATION IN A .. | 1 0.01 99.09 SONG SH, GRAY TA. NOT ALL RAISED BLOO.. | 1 0.01 99.10 SOUSA L, SA MJ, CERQUEIRA JJ, MARTINS.. | 1 0.01 99.11 SOUSA, L., DE SA, J., SA,M.J., CERQUE.. | 1 0.01 99.12 SOYORAL YU, CANBAZ ET, ERDUR MF, EMRE.. | 1 0.01 99.13 SRIVASTAVA A, PATIL V, PREREIRA YDS. .. | 1 0.01 99.14 ST-ONGE M. ET AL.. L-CARNITINE FOR TH.. | 1 0.01 99.15 STEFOSKI D, BALABANOV R, KO M, STRONG.. | 1 0.01 99.16 STEPHANIE BOUCHER. FATAL STIMULATION .. | 1 0.01 99.17 STOLLBERGER C, RAKUSAN S, SEHNAL E, W.. | 1 0.01 99.18 SUGINO S,INANO T,KISHII J,KOBAYASHI Y.. | 1 0.01 99.19 SUNBUL M,CINCIN A,MAMMADOV C,MUTLU B... | 1 0.01 99.20 TADANO T, TAKAHASHI H, SUGAWARA K, SU.. | 1 0.01 99.21 TAGLIETTI F, DEL NONNO F, BAIOCCHINI .. | 1 0.01 99.22 TAIEB G, ET AL, TRANSIENT PUNCTUATE E.. | 1 0.01 99.23 TAJIMA J ET AL. PERSISTENT HYPOTENSIO.. | 1 0.01 99.24 TAKAHASHI N, KOJIMA T, KANEKO A, HIRA.. | 1 0.01 99.25 TAKAKURA H, ENOMOTO T, UJU Y, YOSHIMI.. | 1 0.01 99.26 TAKAOKA H, NAKAMURA TADASHI, YOSHIMUR.. | 1 0.01 99.27 TAMAGAWA H, IWAMOTO S, TAKAHASHI T, N.. | 1 0.01 99.28 TAMAI Y, KOBAYASHI K.. ACUTE CHOLANGI.. | 1 0.01 99.29 TER HEINE R, VAN DEN BOSCH RT, SCHAEF.. | 1 0.01 99.30 THERAPEUTIC GOODS ADMINISTERATION. PR.. | 1 0.01 99.31 THERAPEUTIC GOODS ADMINISTRATION. PRE.. | 1 0.01 99.32 THERAPEUTIC GOODS ADMINISTRATION. PRE.. | 6 0.06 99.38 THERAPEUTIC GOODS ADMINISTRATION. QUE.. | 1 0.01 99.39 THNG C, BABIKER ZOE, BROWN B, BABU C... | 1 0.01 99.40 THOMPSON A G B., KHAN U A., BROTHWELL.. | 1 0.01 99.41 TINCHON A, OBERNDORFER S, MAROSI C, G.. | 1 0.01 99.42 TOFUKU Y. REGIONAL MEETING OF THE 43R.. | 1 0.01 99.43 TOJO A, MIYASHITA K, KINUGASA S, TAKE.. | 1 0.01 99.44 TOKURIKI A. A CASE OF PSORIASIS ARTHR.. | 1 0.01 99.45 TOMIOKA K. A CASE OF ABNORMALLY INCRE.. | 1 0.01 99.46 TOMONO KAWASE. JAPANESE JOURNAL OF CA.. | 1 0.01 99.47 TSUJI H. VISUAL DERMATOLOGY. 2014;13 .. | 1 0.01 99.48 TSUKITA YOKO, WATANABE KANA AND MORIT.. | 1 0.01 99.49 TSUNEMINE H, ARIMA H, ITOH K, SAKANE .. | 1 0.01 99.50 TWO CASES OF SUSPECTED DRUG-INDUCED L.. | 1 0.01 99.51 UNKNOWN. STUDY ON EFFECT OF PANITUMUM.. | 1 0.01 99.52 UNKNOWN. UNKNOWN. UNKNOWN. | 1 0.01 99.53 UNKNOWN. UNKNOWN. UNKNOWN. 2014;55:25.. | 1 0.01 99.54 VAJDA FE, GRAHAM J, ROTEN A, LANDER C.. | 1 0.01 99.55 VAN DER KAAY DCM, VAN HEEL WJM , DUDI.. | 1 0.01 99.56 VENTRE MB, DONADONI G, RE A, SPINA M,.. | 1 0.01 99.57 VIECELLI A, HESSAMODINI H, AUGUSTSON .. | 1 0.01 99.58 VIECELLI A., HESSAMODINI H., LIM WH, .. | 1 0.01 99.59 VOLC D. M. PARKINSON 2014. FACHARZT 2.. | 1 0.01 99.60 VRIELYNCK P, ROSTOMASHVILI N, DEGROOT.. | 1 0.01 99.61 WACHULA E, ZOK J, ZIOMEK M, WYSOCKI P.. | 1 0.01 99.62 WAKI YUKARI. DISCUSSION ON USEFULNESS.. | 1 0.01 99.63 WANG GS, LE LAIT M-C, HEARD K.. UNINT.. | 1 0.01 99.64 WARING WS, JAMIE H, LEGGETT GE. DELAY.. | 1 0.01 99.65 WARNKE C., STETTNER M., LEHMENSICK V... | 1 0.01 99.66 WARNKE C., STETTNER M., LEHMENSICK V... | 1 0.01 99.67 WARNKE C., STETTNER M., LEHMENSICK V... | 2 0.02 99.69 WATANABE J, SATO K, FUJIKURA Y, HORIU.. | 1 0.01 99.70 WATANABE S, SATO HIROTOMO, ADACHI TOM.. | 1 0.01 99.71 WATARU NISHIDA ET. AL.. INSULIN ADMIN.. | 1 0.01 99.72 WATARU NISHIDA ET.AL. INSULIN ADMINIS.. | 1 0.01 99.73 WATTJES MP, VENNEGOOR A, STEENWIJK MD.. | 1 0.01 99.74 WEIGAND T, WAX P, SMITH E, HART K, BR.. | 2 0.02 99.76 WEINER M, SARANTOPOULOS C, GORDON E. .. | 2 0.02 99.78 WESTERGREN T, HJELMELAND K, KRISTOFFE.. | 1 0.01 99.79 WIEGAND TJ, GORODETSKY RM, GREEN JL, .. | 1 0.01 99.80 WILKINSON K, HERRIN V, LAM J. GO WITH.. | 1 0.01 99.81 WU S. SO RESPIROLOGY. 19TH CONGRESS O.. | 1 0.01 99.82 YAJIMA K,UEHIRA T,OTERA H,KOIZUMI Y,W.. | 1 0.01 99.83 YAMAGA, K. IMMUNE RECONSTITUTION INFL.. | 1 0.01 99.84 YAMAGUCHI SHIGEKI ET AL.. A CASE OF S.. | 1 0.01 99.85 YAMAMOTO Y, YAMAMOTO YASUHIRO, OKAMUR.. | 1 0.01 99.86 YANG CC, DENG JF, LIN TJ. PANCYTOPENI.. | 1 0.01 99.87 YOKOYAMA K, KAWAGISHI K, OOKA S, MUKA.. | 1 0.01 99.88 YOSHIDA F, OKUSU Y, WADA A, HIROE Y, .. | 1 0.01 99.89 YOSHIDA Y, YOSHIDA YOICHIRO, AISU NAO.. | 1 0.01 99.90 YOSHIKAWA K. SAFETY, TOLERABILITY, AN.. | 1 0.01 99.91 YOSHIMI K, YOSHIMI K, KUWATSUKA Y, TA.. | 1 0.01 99.92 YOSHIMOTO H. A CASE OF DISTURBED CONS.. | 1 0.01 99.93 YOSHIMURA N, KAMATA T, TAKEMURA H, UE.. | 1 0.01 99.94 YOSUKE FUKIISHI. A CASE OF COMPLICATE.. | 1 0.01 99.95 YOUNES A, CONNORS JM, PARK SI, HUNDER.. | 1 0.01 99.96 YUKIKO HASUIKE, ET AL.,. ANTI RANKL A.. | 1 0.01 99.97 YUKINAO SANADA ET AL.,. 2010;51(9):1209 | 1 0.01 99.98 YUMA SAKURA, ET AL.. A CASE OF INTERS.. | 1 0.01 99.99 ZHU XIUMEI. SUMMARY OF THE LITERATURE.. | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 6 Apr 2017